| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/17/2005 | US20050037340 Immunoglobulin for use in detection of simian and lymphadenopathy associated viral infection in mammals; immunodiagnostics |
| 02/17/2005 | US20050037339 Methods of selecting internalizing antibodies |
| 02/17/2005 | US20050037338 Method and means for detection of severe acute respiratory syndrome |
| 02/17/2005 | US20050037336 Hepatitis X virus for use in generation of antibody and vaccine compositions for use in diagnosis, prevention and treatment viral infection; immunotherapeutic and diagnostics |
| 02/17/2005 | US20050037334 Method of determining sperm capacitation |
| 02/17/2005 | US20050037332 Pyridylalkyl-amino-substituted spiro(phthalan-1,9'-xanthene) or xanthene compounds that complex zinc; can measure zinc ions with high sensitivity without damaging cells; can measure fluorescence with a long wavelength excitation light |
| 02/17/2005 | US20050037331 Apparatuses and methods for reducing albumin in samples |
| 02/17/2005 | US20050037330 Composition for maintaining organ and cell viability |
| 02/17/2005 | US20050037276 Photoresists processable under biocompatible conditions for multi-biomolecule patterning |
| 02/17/2005 | US20050037026 such as Alzheimer's disease; amyloid precursor proteins; comprises diphtheria toxoid as carrier |
| 02/17/2005 | US20050037011 Associated with a reduction in wingless-related MMTV integration site 5a (Wnt5a) gene expression or activity or protein activity; assessing the level of expression of cyclin D1 or phosphorylation of protein kinase C, calmodulin kinase II, dishevelled, or LEF-1; leukemias, lymphomas, and myelomas |
| 02/17/2005 | US20050037010 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 02/17/2005 | US20050037009 Methods and reagents for protease inhibition |
| 02/17/2005 | US20050037005 5c8 Antigen |
| 02/17/2005 | US20050037003 Administering a soluble lymphotoxin- beta receptor, an antibody directed against LT- beta receptor, or an antibody directed against surface LT ligand with a carrier; multiple sclerosis, vision defects, psoriasis, inflammatory bowel disease; antidiabetic agents |
| 02/17/2005 | US20050036997 Molecular modeling of the binding sites for anisomycin, azithromycin, erythromycin, linezolid, tylosin, carbomycin A, spiramycin, virginiamycin, sparsomycin and blasticidin using the Haloarcular marismortui large ribosomal subunit; drug design and drug screening |
| 02/17/2005 | US20050036992 Novel use of liver X receptor agonists |
| 02/17/2005 | US20050036987 Suicide gene-containing strains of bacteria, fungi, and protists; tumor specific shigella species |
| 02/17/2005 | US20050036943 Methods and compositions for the diagnosis of asthma |
| 02/17/2005 | US20050036908 Biochemical detecting device for magnetic beads and method using the same |
| 02/17/2005 | US20050036906 detectors for analyzing specific components in liquid samples by reaction with reagents comprising cavities into which the liquid is introduced, an air aperture communicating from the interior to the outside, and water repellent coatings around the outlet |
| 02/17/2005 | US20050036903 Measurement, monitoring calcium compound within cooling tower; antiscaling agents; corrosion resistance |
| 02/17/2005 | US20050036132 Apparatus for generating data for determining a property of a gemstone and methods and computer programs for determining a property of a gemstone |
| 02/17/2005 | US20050036020 Electrochemical sensor ink compositions, electrodes, and uses thereof |
| 02/17/2005 | US20050035755 Method for deconvolution of impedance spectra |
| 02/17/2005 | US20050035305 Iterative optical based histology |
| 02/17/2005 | US20050034989 Mixture of gel mincing tube and mesh; dividing; centrifuging; drawing through porous material |
| 02/17/2005 | US20050034986 Exhaust gases; internal combustion engines; electrolytic cells |
| 02/17/2005 | US20050034983 Sensor connection means |
| 02/17/2005 | US20050034824 System and method for controlling a processor including a digester utilizing time-based assessments |
| 02/17/2005 | US20050034542 Sensor comprising mechanical amplification of surface stress sensitive cantilever |
| 02/17/2005 | US20050034509 Underwater sampling and mapping apparatus |
| 02/17/2005 | US20050034506 Golf ball COR testing machine |
| 02/17/2005 | DE10355297B3 Defect detection device for concrete component reinforcement using signal analysis of reflection signals detected by oscillation sensor |
| 02/17/2005 | DE10334164A1 Glaskapillare für die Mikroinjektion und Verfahren zur Herstellung einer Glaskapillare für die Mikroinjektion Glass capillary for microinjection, and methods of preparing a glass capillary for microinjection |
| 02/17/2005 | DE10332854A1 Verwendung des neu-identifizierten humanen Gens 7a5/Prognostin für Tumordiagnostik und Tumortherapie Using the newly-identified human gene 7a5 / Prognostin for tumor diagnosis and tumor therapy |
| 02/17/2005 | DE10332849A1 Arrays immobilisierter Biomoleküle auf Hydrogel-bildenden Oberflächen, deren Herstellung und deren Verwendung Arrays of immobilized biomolecules on hydrogel-forming surfaces, their preparation and their use |
| 02/17/2005 | DE10332848A1 Mikroarrays immobilisierter Biomoleküle, deren Herstellung und Verwendung Microarrays of immobilized biomolecules, their preparation and use |
| 02/17/2005 | DE10331980A1 Verwendung von Calpain zur Identifizierung von schmerzmodulierenden Verbindungen Use of calpain to identify pain-compounds |
| 02/17/2005 | DE10330982A1 Vorrichtung und Verfahren zur simultanen Bestimmung von Blutgruppenantigenen Apparatus and method for the simultaneous determination of blood group antigens |
| 02/17/2005 | DE10313236B4 Vorrichtung für Kraft-Weg-Messungen an Schichten Device for force-displacement measurements on layers |
| 02/17/2005 | DE10304968B4 Vorrichtung zur Bestimmung und/oder Überwachung einer Prozessgröße eines Mediums A device for determining and / or monitoring a process variable of a medium |
| 02/17/2005 | DE10245822B4 Verfahren und Gasmesszelle zur Detektion unterschiedlicher Gase Processes and gas-measuring cell for detection of different gases |
| 02/17/2005 | DE10149684B4 Vorrichtung zur Halterung eines Substanzbibliothekenträgers A device for holding a substance library support |
| 02/17/2005 | CA2827128A1 T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
| 02/17/2005 | CA2555323A1 Polypeptide specific to liver cancer, polynucleotide coding for the polypeptide, and rna molecule suppressing expression of the polypeptide |
| 02/17/2005 | CA2537555A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 02/17/2005 | CA2536685A1 Real-time on-line sensing and control of emulsions in formation fluids |
| 02/17/2005 | CA2535073A1 Method for detecting low levels of a fusion protein |
| 02/17/2005 | CA2535045A1 T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
| 02/17/2005 | CA2534973A1 Anti-fcrn antibodies for treatment of auto/allo immune conditions |
| 02/17/2005 | CA2534909A1 P16 mediated regulation of nmda receptors |
| 02/17/2005 | CA2534898A1 Bispecific antibodies for inducing apoptosis of tumor and diseased cells |
| 02/17/2005 | CA2534815A1 Method for the detection of abnormally glycosylated proteins |
| 02/17/2005 | CA2534739A1 Complexes of gpcr142 and relaxin3 or insl5, and their production and use |
| 02/17/2005 | CA2534708A1 Targeted carrier fusions for delivery of chemotherapeutic agents |
| 02/17/2005 | CA2534661A1 Osteoarthritis biomarkers and uses thereof |
| 02/17/2005 | CA2534658A1 Trefoil factor 3 (tff3) as a target for anti-cancer therapy |
| 02/17/2005 | CA2534362A1 Erbb receptor methods and kits for monitoring chemotherapy resistance |
| 02/17/2005 | CA2534216A1 Methods and apparatus for screening for chromosomal abnormalities |
| 02/17/2005 | CA2534109A1 A method of compensating for a measuring error and an electronic arrangement to this end |
| 02/17/2005 | CA2533990A1 Selective pharmacologic inhibition of protein trafficking and related methods of treating human diseases |
| 02/17/2005 | CA2533922A1 Primary rat hepatocyte toxicity modeling |
| 02/17/2005 | CA2533698A1 Lanthanide complexes preparation and uses thereof |
| 02/17/2005 | CA2533557A1 Novel peptide interacting with anti-apoptotic proteins of a bcl-2 family |
| 02/17/2005 | CA2533550A1 Antigen delivery system |
| 02/17/2005 | CA2532866A1 Use of protein sahh as a marker for colorectal cancer |
| 02/17/2005 | CA2532721A1 Ra antigenic peptides |
| 02/17/2005 | CA2532711A1 Coating of porous, surface functionalized, superparamagnetic crystal-containing polymer particles with polyisocyanate/diol and/or epoxide monomers |
| 02/17/2005 | CA2532312A1 Process for the production of fine chemicals in plants |
| 02/17/2005 | CA2531916A1 Animal model for the analysis of tumor metastasis |
| 02/17/2005 | CA2531501A1 Reagents, methods and kits for detecting feed enzymes |
| 02/17/2005 | CA2531191A1 Use of protein psa3 as a marker for colorectal cancer |
| 02/17/2005 | CA2530497A1 Improved electrophysiological assays using oocytes that express human enac and the use of phenamil to improve the effect of enac enhancers in assays using membrane potential reporting dyes |
| 02/17/2005 | CA2530477A1 Use of protein acidic ribosomal protein po (rla-0) as a marker for colorectal cancer |
| 02/17/2005 | CA2529623A1 Antibodies specific for sclerostin and methods for increasing bone mineralization |
| 02/17/2005 | CA2529605A1 Methods and systems for the annotation of biomolecule patterns in chromatography/mass-spectrometry analysis |
| 02/17/2005 | CA2528606A1 Gene expression profiling in primary ovarian serous papillary tumors and normal ovarian epithelium |
| 02/17/2005 | CA2528025A1 Nucleic acid arrays for detecting multiple strains of a non-viral species |
| 02/17/2005 | CA2526900A1 Truncated fragments of alpha-synuclein in lewy body disease |
| 02/17/2005 | CA2526274A1 Prostate stem cell antigen (psca) variants and subsequences thereof |
| 02/17/2005 | CA2525531A1 Method for testing ghrelin release |
| 02/16/2005 | EP1507148A1 Method for detecting carcinomas in a solubilized cervical body sample |
| 02/16/2005 | EP1507147A1 Method for detecting low levels of a fusion protein |
| 02/16/2005 | EP1507146A1 Bioassay method, bioassay device, and bioassay substrate |
| 02/16/2005 | EP1507145A1 Biomolecular substrate, method of testing or diagnosis with use thereof and apparatus therefor |
| 02/16/2005 | EP1507143A1 Analyzer, analyzer pack, cartridge provided with the packs, method of producing the pack, analyzing device, and mechanism for taking out object |
| 02/16/2005 | EP1507139A2 Arrays for multiplexed surface plasmon resonance detection of biological molecules |
| 02/16/2005 | EP1507006A1 Method of screening remedy for renal failure |
| 02/16/2005 | EP1507000A2 A thermostable ligase mediated DNA amplification system for the detection of genetic diseases |
| 02/16/2005 | EP1506998A1 An in vitro tumor angiogenesis model |
| 02/16/2005 | EP1506784A1 Identification of novel factors that block programmed cell death or apoptosis by targeting JNK |
| 02/16/2005 | EP1506700A1 Plasma torch for microwave induced plasmas |
| 02/16/2005 | EP1506513A2 System for point of care diagnosis and/or analysis |
| 02/16/2005 | EP1506412A1 Diagnostics and therapeutics for diseases associated with vasoactive intestinal peptide receptor 2 (vpac2) |
| 02/16/2005 | EP1506411A1 Method for identifying type-i interferon responsive ms patients by determining trail expression |
| 02/16/2005 | EP1506410A1 Polymorphism of soat1 useful for identifying risk of developing alzheimer's disease |
| 02/16/2005 | EP1506409A1 Assays for modulators of asparaginyl hydroxylase |
| 02/16/2005 | EP1506408A2 Methods for diagnosing htlv-i-mediated diseases |
| 02/16/2005 | EP1506407A2 Method for the detection and/or characterisation of circulating tumour cells and the use thereof in the early diagnosis, prognosis and diagnosis of relapses and in the selection and evaluation of therapeutic treatments |